MedTrace Logo

Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke

NCT06576466 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2025-07-08

No results posted yet for this study

Summary

Stroke is a leading cause of disability and the second leading cause of death worldwide. Most strokes are ischemic, caused by acute arterial occlusion. Post-stroke treatment focuses on secondary prevention and rehabilitation, but few treatments address functional recovery. Creatine, a supplement known for improving physical performance, may aid in the recovery of stroke patients, reducing sarcopenia and improving strength among other effects. This pilot study will investigate the effectiveness of creatine supplementation in enhancing physical and functional recovery in ischemic stroke patients. The study will involve a randomized, double-blind clinical trial comparing creatine monohydrate to a placebo.

Conditions

  • Stroke, Ischemic

Interventions

DIETARY_SUPPLEMENT

Creatine monohydrate

Creatine monohydrate. Guinama brand with CE marking. Code 89823.

OTHER

Placebo

Dextrinomaltose. Guinama brand with CE marking. Code 91146.

Sponsors & Collaborators

  • Comunidad Autónoma de las Islas Baleares (Dirección General de Investigación en Salud, Formación y Acreditación)

    collaborator UNKNOWN

  • Fundació d'investigació Sanitària de les Illes Balears

    lead OTHER_GOV

Principal Investigators

  • Raquel Delgado Mederos, PhD · Fundació d'investigació Sanitària de les Illes Balears

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-27
Primary Completion
2027-02-01
Completion
2027-07-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06576466 on ClinicalTrials.gov